Crossmark

Flexibility in the FDA approach to orphan drug development

Crossref DOI link: https://doi.org/10.1038/nrd.2017.151

Published Online: 2017-09-01

Published Print: 2017-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hunter, Nina L.

Rao, Gayatri R.

Sherman, Rachel E.
License Information

Text and Data Mining valid from 2017-09-01
More Information

Article History

First Online: 1 September 2017

Competing interests

: The authors declare no competing financial interests.